AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23553534
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin placebo
Trial: 20840754
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 15 mg TID
Trial: 20840754
Drug: Oxybutynin hydrochloride
RxNorm normalized name: Oxybutynin hydrochloride
DrugBank: Oxybutynin (DB01062)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxybutynin hydrochloride 2.5 mg TID
Trial: 18385265
Drug: Sugammadex 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 2.0 mg kg(‐1) for reversal of rocuronium 0.6 mg kg(‐1)
Trial: 18385265
Drug: Neostigmine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 50 microg kg(‐1) for reversal of cisatracurium 0.15 mg kg(‐1)
Trial: 12797397
Drug: Time-intensified FEC-G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-intensified FEC-G (500, 75, 500 every 14 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Trial: 12797397
Drug: Standard-dose FEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose FEC (500, 75, 500 every 21 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Trial: 12797397
Drug: Time-intensified MMM-G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-intensified MMM-G (mitoxantrone 10, methotrexate 35 every 14 days and mitomycin C 10 every 28 days) with lenograstim (G-CSF 150 microg/m2/day s.c. for 10 days)
Trial: 12797397
Drug: Time-intensified FEC-G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time-intensified FEC-G
Trial: 12797397
Drug: Standard-dose FEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose FEC
Trial: 12797397
Drug: Both intensified
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both intensified regimens (FEC-G and MMM-G)
Trial: 12797397
Drug: Both anthracycline-containing
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both anthracycline-containing regimens (FEC-G and standard FEC)
Trial: 10895336
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine 0.1 mg/kg for intra- and postoperative analgesia
Trial: 1577049
Drug: Intraarticular indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarticular indomethacin 10 mg
Trial: 31379118
Drug: Magnesium isoglycyrrhizinate
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium isoglycyrrhizinate (MgIG) low dose (Group A)
Trial: 31379118
Drug: Magnesium isoglycyrrhizinate
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium isoglycyrrhizinate (MgIG) high dose (Group B)
Trial: 29171661
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal oxygen at a flow rate of 30-70 l.min-1 via nasal cannulae
Trial: 29171661
Drug: Standard oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oxygen therapy at 10 l.min-1 via a bite block
Trial: 27418275
Drug: mHealth device
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth device plus weekly motivational support
Trial: 22196778
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (aspirin, thienopyridine, and vitamin K antagonist)
Trial: 20691446
Drug: COX-1 gene
RxNorm normalized name: Immature cell growth-inhibiting gene 1 protein
DrugBank: Cerliponase alfa (DB13173)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: COX-1 gene polymorphisms (‐842A>G and 50C>T)
Trial: 12095064
Drug: Tretinoin 0.1%
RxNorm normalized name: TRETINOIN 0.1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.1% microsponge gel
Trial: 10194968
Drug: Response preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Response preparation initiated with a precue (colored square)
Trial: 10194968
Drug: Response preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Response preparation during memory scanning
Trial: 10194968
Drug: Difficulty of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Difficulty of concurrent memory search
Trial: 7748046
Drug: Class I
RxNorm normalized name: HLA class I antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class I and III antiarrhythmic drugs
Trial: 25588
Drug: Prolyl-leucyl-glycinamide (MIF-I)
RxNorm normalized name: L-valine, l-tyrosyl-l-leucyl-l-.alpha.-glutamyl-l-prolylglycyl-l-prolyl-l-valyl-l-threonyl-
DrugBank: Ovemotide (DB19156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolyl-leucyl-glycinamide (MIF-I) 75 mg/day
Trial: 25588
Drug: Prolyl-leucyl-glycinamide (MIF-I)
RxNorm normalized name: L-valine, l-tyrosyl-l-leucyl-l-.alpha.-glutamyl-l-prolylglycyl-l-prolyl-l-valyl-l-threonyl-
DrugBank: Ovemotide (DB19156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolyl-leucyl-glycinamide (MIF-I) 750 mg/day
Trial: 12610404
Drug: Anesthetic blocks
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthetic blocks of a compound of bupivacaine with adrenaline associated with clonidine at the frontal branch and sometimes the nasal branch levels of the ophthalmic nerve.
Trial: 11120691
Drug: Cariporide 120
RxNorm normalized name: Cariporide
DrugBank: Cariporide (DB06468)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariporide 120 mg every 8 hours
Trial: 11120691
Drug: Cariporide 20
RxNorm normalized name: Cariporide
DrugBank: Cariporide (DB06468)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariporide 20 mg every 8 hours
Trial: 11120691
Drug: Cariporide 80
RxNorm normalized name: Cariporide
DrugBank: Cariporide (DB06468)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariporide 80 mg every 8 hours
Trial: 8269445
Drug: 3-mg tablets
RxNorm normalized name: lusutrombopag 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-mg tablets of reformulated, micronized glyburide (Glynase PresTab tablets)
Trial: 8269445
Drug: 5-mg tablets
RxNorm normalized name: dronabinol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg tablets of original glyburide (Micronase tablets)
Trial: 3884218
Drug: Pseudoephedrine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (4 mg/kg/day)
Trial: 3884218
Drug: Chlorpheniramine (0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine (0.35 mg/kg/day)
Trial: 29848328
Drug: Micro-fragmented adipose
RxNorm normalized name: human adipose preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-fragmented adipose tissue injection
Trial: 31694851
Drug: Intravenous sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sildenafil (loading dose of 0.4 mg/kg in 3 hours; followed by continuous infusion of 1.6 mg/kg/day)
Trial: 31694851
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) (dosed at 20 ppm)
Trial: 25158846
Drug: Standard moist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard moist wound therapy
Trial: 17293706
Drug: Metformin (850-2550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850-2550 mg/day)
Trial: 10411245
Drug: Sarns oxygenator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarns oxygenator with 0.0375 g of albumin/100 ml prime
Trial: 10411245
Drug: Sarns oxygenator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarns oxygenator with 0.125 g of albumin/100 ml prime
Trial: 10411245
Drug: Medtronic oxygenator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medtronic oxygenator with 0.0375 g of albumin/100 ml prime
Trial: 10411245
Drug: Medtronic oxygenator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medtronic oxygenator with 0.125 g of albumin/100 ml prime
Trial: 2083406
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid treatment (beclomethasone)
Trial: 21334852
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (500 mg three times a day for 2 weeks)
Trial: 19723429
Drug: Brushing for
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brushing for 180 seconds with 1.5 g Aquafresh Advanced dentifrice
Trial: 19723429
Drug: Brushing for
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brushing for 120 seconds with 1.5 g Aquafresh Advanced dentifrice
Trial: 9892228
Drug: Human regular
RxNorm normalized name: Human regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human regular insulin (0.075 U/kg lean body mass)
Trial: 9892228
Drug: Insulin analog
RxNorm normalized name: insulin analog, glargine 300 UNT Pen Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin analog lispro (0.075 U/kg lean body mass)
Trial: 6767404
Drug: Mestranol 50
RxNorm normalized name: Mestranol 50 microgram and norethindrone 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mestranol 50 micrograms and norethindrone 1 mg
Trial: 6767404
Drug: Ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ethinyl estradiol 50 micrograms and norethindrone 1 mg
Trial: 6767404
Drug: Ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ethinyl estradiol 35 micrograms and norethindrone 1 mg
Trial: 6767404
Drug: Ethinyl estradiol
RxNorm normalized name: Ethinyl Estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ethinyl estradiol 30 micrograms and levonorgestrel 150 mg
Trial: 24926949
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU of oral vitamin D2 daily (Arm A)
Trial: 24926949
Drug: 1000 IU
RxNorm normalized name: D 1000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 IU daily in summer/fall and 2000 IU in winter/spring (Arm B)
Trial: 23441533
Drug: Other treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatments for renal anemia
Trial: 20212395
Drug: Nebulized L‐epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized L‐epinephrine (LE)
Trial: 20212395
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BD) 200 mg
Trial: 20212395
Drug: Intramuscular dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular dexamethasone (D) 0.6 mg/kg
Trial: 18411237
Drug: Low-dose naloxone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose naloxone infusion (0.25 microg/kg per hour)
Trial: 8390368
Drug: granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: granisetron 3 mg
Trial: 9360939
Drug: Bacterial lysate
RxNorm normalized name: Thermus thermophilus lysate
DrugBank: Thermus thermophilus lysate (DB11227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacterial lysate treatment for three months
Trial: 1942929
Drug: Intraarterial administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarterial administration of cisplatinum
Trial: 1942929
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of cisplatinum
Trial: 7461024
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg oral digoxin
Trial: 7461024
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg oral digoxin
Trial: 7461024
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg oral digoxin
Trial: 7461024
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg oral digoxin
Trial: 7461024
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg oral digoxin
Trial: 23652826
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (simvastatin 40 mg and ezetimibe 10 mg daily)
Trial: 23652826
Drug: Statin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin monotherapy (simvastatin 40 mg daily)
Trial: 27736028
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and intracoronary melatonin
Trial: 24167976
Drug: Hochuekkito (TJ‐41)
RxNorm normalized name: TJ-CD4B/ABL111
DrugBank: Givastomig (DB18618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hochuekkito (TJ‐41) 7.5 g/day for 7 days before surgery
Trial: 19468545
Drug: dexametasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexametasone (8 mg)
Trial: 9466094
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg kg‐1 h‐1)
Trial: 9466094
Drug: Midazolam (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.06 mg kg‐1 h‐1)
Trial: 9466094
Drug: Gamma-hydroxybutyrate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-hydroxybutyrate (20 mg kg‐1 h‐1)
Trial: 3667022
Drug: Sucrose (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (81 +/- 18 g)
Trial: 3667022
Drug: Caffeine (384
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (384 +/- 13 mg)
Trial: 3667022
Drug: Sucrose (72
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (72 +/- 22 g) plus caffeine (396 +/- 29 mg)
Trial: 29421772
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CQ10) supplementation 100 mg/d for 12 weeks
Trial: 26694632
Drug: 2% chamomile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chamomile gel applied twice daily for 1 month
Trial: 26694632
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied twice daily for 1 month
Trial: 24462464
Drug: Nitroglycerin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin plus oral vinorelbine plus cisplatin
Trial: 24462464
Drug: Oral vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vinorelbine plus cisplatin alone (placebo)
Trial: 20006908
Drug: Spectacles plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectacles plus patching >or=8 hours daily 6 days a week
Trial: 20006908
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (daily and alternate-day occlusion)
Trial: 9489595
Drug: Morphine delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine delivered over 40 seconds with a 5 min lockout interval
Trial: 9489595
Drug: Morphine delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine delivered over 5 minutes with a 1 min lockout interval
Trial: 7827744
Drug: Intermittent pneumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent pneumatic compression (IPC) twice weekly for one hour each session
Trial: 3413461
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg slow-release pindolol once daily
Trial: 3413461
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg pindolol three times daily
Trial: 20616787
Drug: Watermelon supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Watermelon supplementation (L-citrulline/L-arginine, 2.7 g/1.3 g/day)
Trial: 18221288
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg udenafil
Trial: 21934637
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg udenafil
Trial: 19101739
Drug: ART (Atraumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART (Atraumatic Restorative Treatment)
Trial: 10925662
Drug: EHF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHF therapy + magnetotherapy + drugs
Trial: 10925662
Drug: Standard drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drug therapy
Trial: 14621839
Drug: 3 pulses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 pulses of 8 mg/kg methylprednisolone (MPS) in an alternate‐day regimen (total dose 25 mg/kg in 1 week)
Trial: 14621839
Drug: 5 daily
RxNorm normalized name: Alberto VO5 Daily Revitalizing Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 daily pulses of 3 mg/kg MPS (total dose 17 mg/kg)
Trial: 12000000
Drug: Easyhaler (budesonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Easyhaler (budesonide 800 microg day(-1), 200 g dose(-1), two inhalations twice daily for 12 weeks)
Trial: 12000000
Drug: Turbuhaler (budesonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler (budesonide 800 microg day(-1), 200 g dose(-1), two inhalations twice daily for 12 weeks)
Trial: 2271378
Drug: Frusemide 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide 40 mg (F)
Trial: 2271378
Drug: Frusemide 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide 40 mg in combination with triamterene 50 mg (F+T)
Trial: 25832102
Drug: Single MenC-CRM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MenC-CRM dose at 3 months
Trial: 25832102
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of MenC-CRM at 3 and 4 months
Trial: 25832102
Drug: Single MenC-polysaccharide-TT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single MenC-polysaccharide-TT dose at 3 months
Trial: 25832102
Drug: No MenC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No MenC doses
Trial: 22457418
Drug: Lipid emulsion
RxNorm normalized name: propofol lipid emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid emulsion (LPD) group received 100 mL of a 20% soybean oil emulsion for 7 days after esophagectomy.
Trial: 22457418
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received parenteral feeding with a glucose-based solution only.
Trial: 17284127
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day of aripiprazole
Trial: 17284127
Drug: 6 mg/day
RxNorm normalized name: EMSAM 6 MG/Day 24HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/day of risperidone
Trial: 3497780
Drug: Sustained-release tiaprofenic
RxNorm normalized name: tiaprofenate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release tiaprofenic acid 600 mg once daily
Trial: 3497780
Drug: Standard tiaprofenic
RxNorm normalized name: tiaprofenate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard tiaprofenic acid 300 mg tablets twice daily
Trial: 3548295
Drug: pre drug
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pre drug control
Trial: 21247247
Drug: Candesartan (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (up to 12 mg/day)
Trial: 21247247
Drug: Amlodipine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (up to 10 mg/day)
Trial: 17701889
Drug: NN414 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN414 1.5 mg/kg
Trial: 17701889
Drug: NN414 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN414 4.5 mg/kg
Trial: 17701889
Drug: NN414 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN414 10 mg/kg
Trial: 17701889
Drug: NN414 (1.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN414 (1.5, 4.5, and 10 mg/kg)
Trial: 11727838
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (7.5 mg/week) combined with Naproxen (1000 mg/day)
Trial: 11727838
Drug: Naproxen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (1000 mg/day) alone
Trial: 9859964
Drug: N-acetylcysteine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (3 g of the 20% liquid solution) 1 hour before each dose of TMP-SMX (trimethoprim 80 mg, sulfamethoxazole 400 mg) twice daily
Trial: 2681559
Drug: 4x1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4x1 g ampicillin intravenously over 3 days
Trial: 28960033
Drug: DA-9601 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-9601 (3 times daily for 2 weeks)
Trial: 28960033
Drug: DA-5204 (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-5204 (twice daily for 2 weeks)
Trial: 10168895
Drug: Laser photocoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser photocoagulation and aspirin treatment
Trial: 27397060
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus vildagliptin 100 mg (InsV)